News | Susan G. Komen®️

All News

RSS

News Releases

Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of New Mexicans

January 11, 2023 Press Releases

Introduction of Diagnostic and Supplemental Imaging Legislation Could Benefit Thousands of Missourians

January 10, 2023 Press Releases

Susan G. Komen® MORE THAN PINK Walk Raises Funds for Breast Cancer Patient Care Services in West Palm Beach

December 12, 2022

Susan G. Komen^® Names Dr. Ann H. Partridge as New Chief Scientific Advisor

December 7, 2022 Press Releases

Susan G. Komen 2022 3-Day Event Series Wraps Up Raising $14M

December 1, 2022 Press Releases

Ready® Unites with Susan G. Komen® against Breast Cancer

October 20, 2022

Susan G. Komen® Hosts Annual Metastatic Breast Cancer Collaborative Research Summit

October 13, 2022

Susan G. Komen® Advocates to Congress: People with Terminal Breast Cancer Cannot Wait for Federal Help

October 13, 2022 Press Releases

1 … 40 41 42 43

Recent Podcasts

Artificial Intelligence is buzzy. There’s a lot about it in the news and a lot we think we understand about how to use it and a lot we may not fully understand. But the promise it holds is tremendous, and today we’re going to learn a little more about how it could benefit breast cancer research and patient care in the near future. Drs. Charles Perou at UNC Chapel Hill and Erika Crosby at Duke University are two very accomplished breast cancer researchers who are joining us today to share their perspectives on using AI now and in the future.

Leveraging AI In Breast Cancer ResearchJuly 20, 2026
We know that clinical trials are a critical lifeline, offering new ways to prevent, detect, diagnose and treat breast cancer. Today, patient advocates are transforming clinical trials by bringing the real-world experiences of patients directly to researchers. By acting as a bridge between science and the community, patient advocates boost enrollment in clinical trials, and help build a lasting trust Today we are speaking with Dr. Lior Braunstein, a radiation oncologist and researcher at Memorial Sloan Kettering Cancer Center, and Dr. Ellen Landsberger, a retired OB-GYN and patient advocate, also at Memorial Sloan Kettering Cancer Center. Together they are working on the ARCHER clinical trial, a study that is investigating a new treatment strategy for HER2-positive metastatic breast cancer. We’ll talk about what they are hoping to accomplish through the ARCHER trial, what their collaborative process looks like and how patient advocates in clinical trials can help improve patient outcomes.

Designing Better Clinical Trials: Why Patient Advocates Belong at the TableJuly 13, 2026
At just 32 years old, Keisha Kinison was working in women's health when she suddenly found herself as the patient. In this episode, we'll talk about what it was like to discover her diagnosis before a physician had the chance to call, why she made the difficult decision to change doctors during treatment, how her experience transformed her and the incredible support that helped carry her through. Woven throughout every chapter of her story is one powerful message: trust yourself, advocate for yourself, and never be afraid to seek the care you deserve.

When Your Voice Saves Your LifeJuly 6, 2026

View All

Susan G. Komen Newsroom

Get the latest news and updates from Susan G. Komen